Life Science Instrumentation Market

The global life science instrumentation market is projected to reach USD 92.53 billion by 2031 from USD 63.4  billion in 2025, at a CAGR of 6.5% from 2025 to 2030. The life science instrumentation market is expected to witness steady growth over the next five years, driven by the increasing adoption of advanced analytical and research instruments across R&D activities. The expansion of manufacturing capabilities among pharmaceutical and biopharmaceutical companies, along with rising demand from applied industries such as clinical diagnostics, environmental testing, and food analysis, will continue to support market growth. Additionally, ongoing advancements in next-generation sequencing (NGS) technologies and the growing burden of infectious diseases are further accelerating the need for high-performance instrumentation.

At the same time, the market is likely to remain moderately competitive, with established global players alongside emerging companies competing to gain market share through innovation and product differentiation. Continuous technological developments, strategic collaborations, and a focus on improving efficiency and accuracy in life science research are expected to shape the competitive landscape and drive sustained growth in the coming years.

To know about the assumptions considered for the study download the pdf brochure

As of 2025, the leading participants in the global life science instrumentation market include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Agilent Technologies, Inc. (US), Waters Corporation (US), Shimadzu Corporation (Japan), Becton, Dickinson and Company (US), PerkinElmer Inc. (US), Bio-Rad Laboratories, Inc. (US), Bruker (US), and Hitachi High-Technologies Corporation (Japan), among others. These companies employ a range of strategic initiatives, such as mergers & acquisitions, collaborations, partnerships, and product launches, to strengthen their presence and expand their market share globally.

Thermo Fisher Scientific Inc. (US):

Thermo Fisher Scientific is a leading provider of life science instrumentation, delivering comprehensive solutions that span analytical technologies, laboratory automation, and high-performance detection systems. The company’s product portfolio includes cutting-edge instruments such as mass spectrometers, liquid & gas chromatographs, electron microscopes, and molecular spectroscopy systems, which are essential for applications in genomics, proteomics, metabolomics, and cell biology. Through its brands like Thermo Scientific, Applied Biosystems, Invitrogen, and Fisher Scientific, the company serves academic research institutions, pharmaceutical & biotechnology companies, and clinical laboratories worldwide. Thermo Fisher also invests heavily in R&D to integrate digital tools, AI, and automation into its instruments, enhancing precision, reproducibility, and throughput for complex biological analyses. Its strong focus on innovation and customer-driven solutions positions it as a key enabler of scientific advancements in life science research and healthcare. The company operates in more than 50 countries across North America, Europe, APAC, and Latin America. Some of the company's major subsidiaries include Thermo Informatics Asia Pacific Pty Ltd. (Australia), Thermo Measurement Ltd. (UK), Thermo Instruments Inc. (Canada), Thermo Ramsey Italia S.r.l. (Italy), Thermo Fisher Scientific LLC (US), and Thermo Life Sciences AB (Sweden), among others. The company has adopted inorganic growth strategies such as acquisitions to strengthen its market position.

Danaher Corporation (US):

Danaher Corporation is a global leader in life science instrumentation, offering a diverse portfolio of analytical and research technologies that drive innovation across biotechnology, pharmaceuticals, and academic research. Through its renowned brands, such as Cytiva, Beckman Coulter Life Sciences, Leica Microsystems, and Molecular Devices, the company delivers high-precision instruments for applications including genomics, proteomics, cell analysis, and structural biology. Its solutions span chromatography systems, flow cytometers, centrifuges, microscopes, and molecular imaging platforms, enabling scientists to explore complex biological processes with greater accuracy and speed. Danaher emphasizes continuous innovation through its proprietary Danaher Business System (DBS), fostering operational excellence and customer-driven development. With growing integration of automation, digital workflows, and AI-powered data analysis, the company is enhancing research efficiency, bioprocess optimization, and clinical translation, making it a key enabler of scientific discovery and healthcare advancement worldwide.

Agilent Technologies, Inc. (US):

Agilent Technologies is a leading provider of life science instrumentation and analytical solutions, serving the pharmaceutical, biotechnology, academic, and clinical research sectors. The company’s comprehensive portfolio spans mass spectrometry, liquid and gas chromatography, atomic and molecular spectroscopy, microplate readers, and next-generation sequencing sample preparation systems. These tools are essential for applications in genomics, proteomics, metabolomics, and biopharmaceutical quality control. Agilent also integrates advanced software, automation, and digital analytics to deliver end-to-end laboratory workflows that enhance precision, throughput, and data integrity. Its instruments are widely used in drug development, disease research, and environmental and food testing. With continued investment in R&D and sustainability initiatives, Agilent focuses on advancing precision measurement technologies and life science innovation, enabling scientists and healthcare professionals to gain deeper biological insights and accelerate discovery from lab to clinic. The company serves various industries, including pharmaceutical & biotechnology, chemical & energy, environmental testing labs, and contract manufacturing organizations. Some of its major subsidiaries include Agilent Technologies Australia Pty. Ltd., Agilent Technologies Canada, Inc., Agilent Technologies (Cayman Islands) Ltd., and Agilent Technologies (Shanghai) Company Ltd. (China).

Market Ranking

The global life science instrumentation market is relatively concentrated, with five major players—Thermo Fisher Scientific Inc. (US), Agilent Technologies (US), Danaher Corporation (US), Waters Corporation (US), and Shimadzu Corporation (Japan)—collectively accounting for approximately 30–35% of the market share. A strong driver for Thermo Fisher Scientific, Danaher Corporation, and Shimadzu Corporation in the life science instrumentation market is the growing global demand for advanced analytical technologies to support biopharmaceutical research, clinical diagnostics, and precision medicine. Rising investments in proteomics, genomics, and cell-based research are driving demand for high-performance instruments, including mass spectrometers, chromatographs, and microscopy systems. Thermo Fisher benefits from its expansive product portfolio and integration of digital and automation solutions; Danaher leverages its strong brands and the Danaher Business System (DBS) to drive innovation and operational excellence; while Shimadzu focuses on precision analytical technologies, sustainability, and expanding its R&D capabilities. Together, these companies are propelled by increasing government and private-sector funding for life sciences, the shift toward biologics and personalized medicine, and continuous technological advancements that enhance sensitivity, accuracy, and throughput in laboratory workflows.

The remaining 65–70% of the market is fragmented among regional and specialized companies, which continue to drive innovation and create opportunities for startups. Overall, competitive dynamics are shaped by the growing demand for life science instrumentation solutions.

Related Reports:

Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, NGS, PCR, Microscopy, Centrifuge, Liquid Handling), Application (Diagnostic, Research), End User (Pharma-Biopharma, Food, Hospital, Academia, CRO) - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]